Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
4.550
+0.020 (0.44%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $215.87 million as of April 17, 2025. Its market cap has increased by 337.83% in one year.
Market Cap
215.87M
Enterprise Value
126.68M
1-Year Change
337.83%
Ranking
Category
Stock Price
$4.55
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has decreased from $222.39M to $215.87M, a decrease of -2.93%. That is a compound annual growth rate of -0.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 215.87M | -41.45% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 750.23B |
| UnitedHealth Group | 445.32B |
| Johnson & Johnson | 377.86B |
| AbbVie | 306.14B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.22B |
| AstraZeneca | 210.38B |
| Novartis AG | 210.23B |